Cytovance Biologics and PolyPeptide Announce Collaboration for Peptide Medicines Expressed in Microbes and Mammals Investing.com
- This collaboration offers an integrated solution for customers looking to outsource the development and production of microbial and mammalian expressed peptide drugs, with scalable options that address the full range of product requirements.
OKLAHOMA CITY & TORRANCE, Calif.–( BUSINESS WIRE )–In response to the growing demand for peptide medicines, Cytovance Biologics and PolyPeptide have announced a partnership that combines Cytovance’s expertise in microbial and mammalian expression, process development and cGMP manufacturing with PolyPeptide’s development capabilities and production of complex peptides.
This announcement contains multimedia. See the entire issue here: https://www.businesswire.com/news/home/20250113598664/en/
Axel Schleyer, CCO of Cytovance Biologics: For two decades, Cytovance has supported the development and expansion of biologics expressed in microbes and mammals. The combination of our strengths with PolyPeptide is exactly what our customers and the industry need to support the rapidly growing market demand.
Trishul Shah, PolyPeptide Director of Business Development: With more than 1,000 therapeutic peptides in production, PolyPeptide offers in-depth peptide development and synthesis capabilities. The collaboration gives users access to complementary technology portfolios to drive their innovative drug development projects.
The two companies have already collaborated on specific customer projects. The new collaboration expands the partnership to benefit drug developers seeking additional capacity, rapid scale-up and increased efficacy, helping to advance new peptide products into the clinic and to market.
See the original version on businesswire.com: https://www.businesswire.com/news/home/20250113598664/en/
For inquiries about Cytovance media, please contact:
media@elementcg.co
@Cytovance Biologics “ follow us further LinkedIn
For inquiries about PolyPeptide media, please contact:
mediateam@polypeptide.com
@PolyPeptide “ follow us on LinkedIn
Source: Cytovance Biologics
